Table 1 Patients’ demographic and clinical characteristics at baseline
All (n = 50) | Groups | P-value | ||
|---|---|---|---|---|
TM (n = 25) | HM (n = 25) | |||
Age (mean) ± SD | 74.84 ± 11.8 | 73.68 ± 14.2 | 76.00 ± 8.8 | 0.68 |
Men (mean) | 26 (52.0) | 13 (52.0) | 13 (52.0) | 1.00 |
MLHFQ [95CI] | 24.58 [19.30;29.86] | 20.20 [14.48;25.92] | 28.96 [19.97–37.95] | 0.07 |
EQ5D utilities [95CI] | 0.78 [0.72;0.85] | 0.81 [0.74;0.87] | 0.76 [0.64;0.88] | 0.47 |
Pacing indication (%) | ||||
Sick sinus syndrome | 24 (48.0) | 12 (48.0) | 12 (48.0) | 0.65 |
Atrioventricular block | 20 (40.0) | 11 (44.0%) | 9 (36.0) | |
Chronic AF with Bradycardia | 6 (12.0) | 2 (8.0) | 4 (16.0) | |
Disease manifestations (%) | ||||
Syncope | 14 (28.0) | 8 (32.0) | 6 (24.0) | 0.81 |
Dizziness | 25 (50.0) | 12 (48.0) | 13 (52.0) | |
Dyspnoea | 11 (22.0) | 5 (20.0) | 6 (24.0) | |
Service derivated (%) | ||||
Emergency dept. | 3 (6.0) | 1 (4.0) | 2 (8.0) | 0.51 |
Cardiology ward | 14 (28.0) | 5 (20.0) | 9 (36.0) | |
Primary healthcare | 4 (8.0) | 2 (8.0) | 2 (8.0) | |
Other hospitals | 29 (58.0) | 17 (68.0) | 12 (48.0) | |
Stimulation (%) | ||||
DDDR | 44 (88.0) | 23 (92.0) | 21 (84.0) | 0.33 |
VVIR | 6 (12.0) | 2 (8.0) | 4 (16.0) | |
Comorbidities (%) | ||||
Dislipidemia | 27 (54.0) | 13 (52.0) | 14 (56.0) | 0.50 |
Obesity (BMI > 30) | 1 (2.0) | 0 (0.0) | 1 (4.0) | 0.50 |
Tachyarrhythmia | 18 (36.0) | 7 (28.0) | 11 (44.0) | 0.19 |
Hypertension | 32 (64.0) | 17 (68.0) | 15 (60.0) | 0.38 |
Diabetes Mellitus | 6 (12.0) | 0 (0.0) | 6 (24.0) | 0.01 |
Other comorbidities (%) | ||||
None | 18 (36.0) | 11 (44.0) | 7 (28.0) | 0.39 |
Others | 10 (20.0) | 6 (24.0) | 4 (16.0) | |
Coronary heart diseases | 22 (44.0) | 8 (32.0) | 14 (56.0) | |
Pharmaceutical treatment (%) | ||||
Antiaggregants | 18 (36.0) | 8 (32.0) | 10 (40.0) | 0.38 |
Anticoagulants | 25 (50.0) | 10 (40.0) | 15 (60.0) | 0.13 |
Antiarrhythmics | 18 (36.0) | 7 (28.0) | 11 (44.0) | 0.19 |
Antihypertensives | 32 (64.0) | 18 (72.0) | 14 (56.0) | 0.19 |